Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1817734 | 0.82 | MAPT (0.58) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| SCHEMBL14601142 | 0.80 | ESR1 (0.47) | MAPTKMT2AHIF1ATSHRALDH1A1 | |
| SCHEMBL638306 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| SCHEMBL2208876 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL11833682 | 0.78 | CYP1A2 (0.46) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| SCHEMBL1878464 | 0.78 | CES1 (0.52) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| SCHEMBL11857628 | 0.77 | CYP1A2 (0.52) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| SCHEMBL28024028 | 0.77 | CYP1A2 (0.52) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL27908053 | 0.77 | CYP1A2 (0.52) | CYP1A2CYP2D6KCNN4MAPTKMT2A | |
| SCHEMBL28757096 | 0.77 | CYP1A2 (0.52) | CYP1A2CYP2D6KCNN4MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281668-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-09-11 | — | — | US | claimed |
| EP-4385533-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) | 2024-06-19 | — | — | EP | claimed |
| CN-117658914-A | Naphthalimide photoinitiator, photopolymerizable liquid composition, method and application | 大连理工大学 | 2024-03-08 | — | — | CN | claimed |
| WO-2023020256-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国海洋大学 | 2023-02-23 | — | — | WO | claimed |
| CN-113827779-B | Biological polysaccharide hydrogel and preparation method and application thereof | 中国海洋大学 | 2022-07-26 | — | — | CN | claimed |
| CN-113827779-A | Biological polysaccharide hydrogel and preparation method and application thereof | 中国海洋大学 | 2021-12-24 | — | — | CN | claimed |
| US-4372811-A | INHIBITION OF DEGRADATION OF CARBOHYDRATES | MO OCH DOMSJO AKTIEBOLAG (SE) | 1983-02-08 | — | — | US | claimed |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250281668-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-09-11 | — | — | US | disclosed |
| EP-4385533-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) | 2024-06-19 | — | — | EP | disclosed |
| CN-117903431-A | Carbon nano tube composite material and preparation method and application thereof | 浙江王点科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| WO-2023020256-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国海洋大学 | 2023-02-23 | — | — | WO | disclosed |
| CN-113827779-B | Biological polysaccharide hydrogel and preparation method and application thereof | 中国海洋大学 | 2022-07-26 | — | — | CN | disclosed |
| CN-1551767-A | Treatment of cancer | ��˹��ŵ�� | 2004-12-01 | — | — | CN | disclosed |
| US-4372811-A | INHIBITION OF DEGRADATION OF CARBOHYDRATES | MO OCH DOMSJO AKTIEBOLAG (SE) | 1983-02-08 | — | — | US | disclosed |
| US-4316021-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1982-02-16 | — | — | US | disclosed |
| US-4243813-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| US-4196125-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1980-04-01 | — | — | US | disclosed |
| US-4118573-A | ANTIVIRAL AGENTS | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4018790-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | IAPP, NPPA, ARG1 | CYP1A2 4858/4885CYP2D6 4655/4885KCNN4 4773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.